דרוג:
FeelBetter מצטרפת לשוק של Lightbeam כדי להניע טיפול מבוסס ערך, ולהגדיל את הגישה לפתרונות המשפרים באופן יזום את ניהול התרופות בקרב מטופלים קשישים
FeelBetter, המובילה בתחום הבינה הפרמקו-קלינית המייעלת טיפול מבוסס ערך, הכריזה היום על שותפות עם Lightbeam Health Solutions, המובילה בפתרונות ושירותים לניהול בריאות האוכלוסייה ההופכים תובנות לתוצאות, כדי להפחית את הסיכונים והעלויות של ריבוי תרופות בחולים מעל גיל 65.
FeelBetter Joins Lightbeam’s Marketplace to Drive Value-Based Care, Increasing Access to Solutions That Proactively Improve Medication Management Among Senior Patients
Lightbeam’s Population Health Platform Integrates FeelBetter’s Pharmaco-Clinical Intelligence Solution to Reduce Risks and Costs Associated with Polypharmacy
TEL AVIV, 6 September 2022, (BUSINESS WIRE):
FeelBetter, the leader in pharmaco-clinical intelligence that optimizes value-based care, today announced a partnership with Lightbeam Health Solutions, the leader in population health management solutions and services that transform insights into outcomes, to reduce the risks and costs of polypharmacy in patients over the age of 65.
Polypharmacy, the simultaneous use of multiple medications to treat diseases and other health conditions, can contribute to medication non-adherence, drug interactions, increased adverse events, and poor health outcomes, particularly in senior patients with several chronic conditions. In the United States alone, suboptimal medication management results in 275,000 deaths and more than $528 billion in avoidable costs every year1. To proactively combat these public health risks and reduce associated costs while improving the quality of patient care, FeelBetter and Lightbeam are integrating their solutions to optimize medication management at scale.
“Lightbeam provides data-driven insights to help clients increase quality and efficiency, and extend their reach across the full spectrum of population health management,” said Dr. Kent Locklear, Chief Medical Officer of Lightbeam Health Solutions. “Successful medication management plays a significant role in moving the needle on both quality and cost, and FeelBetter has demonstrated it can deliver on both fronts. We’re thrilled to add FeelBetter’s pharmaco-clinical intelligence technology to the Lightbeam Marketplace.”
Lightbeam provides population health solutions and services for ACOs, payers, health plans, provider groups, and health systems, enabling them to close care gaps, minimize risks, and improve quality of care and quality of life for over 42 million patient lives across the United States. FeelBetter’s SaaS solution – which accurately identifies patients with the highest risk of deterioration, hospitalization, and incurring financial costs due to suboptimal polypharmacy – will be available via the Lightbeam Marketplace, enriching existing claims, clinical, and patient data within the Lightbeam platform. Access to FeelBetter’s solution will also provide Lightbeam’s clients with the capabilities to identify the need for potential clinical interventions and personalize medication regimens for patients.
Liat Primor, FeelBetter’s CEO and Co-Founder added: “We’re excited to collaborate with Lightbeam and leverage their platform’s reach to arm healthcare organizations with actionable insights to help ensure that the medicines patients are prescribed are safe and effective, while providing a tool to significantly reduce rising healthcare costs.”
About Lightbeam Health Solutions
About FeelBetter
Headquartered in Tel Aviv, Israel, FeelBetter's investors include FirstTime Ventures, GoodCompany Ventures, Random Forest VC and Triventures ARC. To learn more about FeelBetter, visit: feelbetter.healthcare.
1 Watanabe, J. H., Mclnnis, T., & Hirsch, J. D. (2018). Cost of Prescription Drug-Related Morbidity and Mortality. The Annals of pharmacotherapy, 52(9), 829-837. https://doi.org/10.1177/1060028018765159
Contacts
Media:
Jacob Gnieski
Amanda Hunt
Source: FeelBetter
תוכן הודעה זו בשפת המקור, הוא הגרסה הרשמית והמהימנה היחידה של מסמך זה. התרגומים הם למטרות נוחות בלבד ויש להצליבם עם המסמך בשפת המקור, שהוא הגרסה היחידה של טקסט זה שהוא בעל תוקף משפטי.
*** הידיעה מופצת בעולם על ידי חברת התקשורת הבינלאומית Business Wire
לפרטים נוספים: נוי תקשורת 03-6026026 זהר 052-2641769
|